|
K
|
KW DRUG DEVELOPMENTS LTD ActiveScientific & Education |
Financial statements of KW DRUG DEVELOPMENTS LTD
According to KW DRUG DEVELOPMENTS LTD latest financial report submitted on 2021-03-31, the company has a Cash of £18,175.00, Total-Assets of £20,015.00 while the Working-Capital is -£246.00. Compared with the previous year, the company reported a Cash increase of 3.22%, which is an equivalent of -585. At the same time, the Total-Assets went up by 1.62%, or by -325.
Turnover 2021
£ -
-
Consolidated A/cs
N
-
Reporting period
12
-
Working Capital
£ -246
-
Profit after Tax
£ -
KW DRUG DEVELOPMENTS LTD Business Credit Report
A Business Credit Report for KW DRUG DEVELOPMENTS LTD is available for instant download. The report will provide you with a credit score and credit limit recommendation for KW DRUG DEVELOPMENTS LTD, payment trends, if the company pays their Invoices on time, whether or not the company has any court judgements, ownership and group structure, up to 5 years of financial statements and much more. When you buy a Credit Report from Global Database, you will also have a 7 days free trial to our B2B Sales Platform.
KW DRUG DEVELOPMENTS LTD
KW DRUG DEVELOPMENTS LTD Directors and key executives
View all employeesKW DRUG DEVELOPMENTS LTD currently employs 1 people. Compared with the previous year, the company has reported a staff increase of 0%, which is an equivalent of 0 employees. In order to view contact information, including emails and phone numbers for all the employees working at KW DRUG DEVELOPMENTS LTD and to export them in XL or to your existing CRM, you can subscribe to our platform here.
Total Employee Count
Total employees
1
100%
1y growth
100%
2y growth
Management Level
Middle
| Employee | Job Title | Phone | Country | |
|---|---|---|---|---|
| Jane Williams | Company Secretary |
-
|
- | GB |
| Keith Williams | Director |
-
|
- | GB |
Get in touch with 2 of contacts working at KW DRUG DEVELOPMENTS LTD
Upgrade to subscriptionKW DRUG DEVELOPMENTS LTD competitors:
View all competitorsTop 5 similar companies of KW DRUG DEVELOPMENTS LTD are HENLEY CENTRE HEADLIGHT VISION LTD, LSE ENTERPRISE LTD, LABOUR RESEARCH DEPARTMENT, NEW POLICY INSTITUTE, COUNCIL FOR BRITISH RESEARCH IN THE LEVANT. View and export all the competitor list of KW DRUG DEVELOPMENTS LTD by upgrading your account here.
HENLEY CENTRE HEADLIGHT VISION LTD
LSE ENTERPRISE LTD
LABOUR RESEARCH DEPARTMENT
NEW POLICY INSTITUTE
COUNCIL FOR BRITISH RESEARCH IN THE LEVANT
KW DRUG DEVELOPMENTS LTD news & activities:
View full activityEBITDA
The KW DRUG DEVELOPMENTS LTD-based company said the adjusted EBITDA is now £259.00, compared with the previous year of 252.
uk.globaldatabase.com
2022-03-31
Employees
KW DRUG DEVELOPMENTS LTD number of employees has decreased by 0% compared with previous year and now represents a total number of 1.
uk.globaldatabase.com
2022-03-31
Frequently Asked Questions regarding KW DRUG DEVELOPMENTS LTD
Where is KW DRUG DEVELOPMENTS LTD registered office?
KW DRUG DEVELOPMENTS LTD is located at PROGRESS HOUSE, 396 WILMSLOW RD WITHINGTON, United Kingdom.
How many people work at KW DRUG DEVELOPMENTS LTD?
According to the latest account statement, there are currently 1 of employees working for KW DRUG DEVELOPMENTS LTD.
What is KW DRUG DEVELOPMENTS LTD EBITDA?
For 2021, KW DRUG DEVELOPMENTS LTD has reported an EBITDA of £259.00, which went down by -2.7% compared to previous year.
What is the Business Credit Score of KW DRUG DEVELOPMENTS LTD and how reliable is the company?
In order to check the business credit score of KW DRUG DEVELOPMENTS LTD, you can request a credit report. You will view the latest credit limit information, ownership, group structure, court judgements and much more.
Does KW DRUG DEVELOPMENTS LTD pay their invoices on time?
By requesting a Business Credit Report for KW DRUG DEVELOPMENTS LTD, you will be able to gain more insights about the KW DRUG DEVELOPMENTS LTD payment trends.
Search for International Credit Report
|
Name
|
City
|
Address
|
Reg. No
|
Status
|
Action |
|---|
